Founded
Address
Other Office
285 Riverside Avenue
Suite 250
Westport, CT 06880
United States
Phone
Website
Industry
Recent investment activity
KANDO id: 30845
Corporate information
Registration country
Company type
Venture capital firm with a focus on early stage technology and healthcare companiesFunds managed
| Fund | Type | Vintage | Currency | Committed capital | IRR | x |
|---|---|---|---|---|---|---|
| Canaan IX LP | Venture | 2012 | ||||
| Canaan VIII LP | Venture | 2007 | 14.50 % | 1.62 x | ||
| Canaan Equity Partners VII | Venture | 2005 | 20.70 % | 3.10 x |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 242| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
0-In Design Automation Inc | Provider of verification products that help verify multi-million gate ASICs and SOC designs. | N/A | |||
| 3Crowd Technologies | Series A | |||||
| Active Network Inc | Series F | |||||
| Active Network Inc | N/A | |||||
| Active Network Inc | Series E | |||||
| Active Network Inc | Series D | |||||
| Adlyfe | Series A | |||||
| Advanced BioHealing Inc | An industry leader in the science of regenerative medicine | Series C | ||||
| Advanced BioHealing Inc | An industry leader in the science of regenerative medicine | Series B | ||||
| Aldea Pharmaceuticals Inc | Venture | |||||
| Altheos Inc | A drug development company focused on next generation intraocular pressure (IOP) lowering agents for glaucoma and ocular hypertension. | Series A | ||||
| Amicus Therapeutics Inc | N/A Initial investment | |||||
|
Aperto Networks Inc | WiMax equipment company. | Series F | |||
|
|
Aperto Networks Inc | WiMax equipment company. | Series E | |||
|
|
Aperto Networks Inc | WiMax equipment company. | Series D | |||
|
|
Aperto Networks Inc | WiMax equipment company. | Series C | |||
| Apieron Inc | Asthma Device Monotoring Maker | Series D | ||||
| Apieron Inc | Asthma Device Monotoring Maker | Series C | ||||
|
Arbor Networks Inc | DDoS attack prevention, network security and visibility solutions company. | N/A Initial investment | |||
| Argon Networks Inc | N/A | |||||
|
Associated Content Inc | Content Publishing Platform | Series B | |||
|
|
Associated Content Inc | Content Publishing Platform | Series C | |||
| BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series C | ||||
| BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series B | ||||
| BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series A |
